JENNIFER SWANSIGER: Open Payments
NPI 1982253217 · BEACHWOOD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$785 in 28 payments from 15 companies in 2025. Trend: 2023 $87 · 2024 $754 · 2025 $785
Food & beverage: $685Education: $100
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $124 |
| ConvaTec Inc. | 3 | $92 |
| UROGEN PHARMA, INC. | 3 | $92 |
| Merck Sharp & Dohme LLC | 3 | $82 |
| Sumitomo Pharma America, Inc. | 3 | $67 |
| IMMUNITYBIO, INC. | 2 | $64 |
| Cycle Pharmaceuticals Inc | 2 | $46 |
| Laborie Medical Technologies Corp. | 2 | $43 |
| ABBVIE INC. | 2 | $40 |
| Medtronic, Inc. | 1 | $36 |
Products named: GENTLECATH GLIDE, KEYTRUDA, GEMTESA, JELMYTO, ANKTIVA, Venxxiva, LUPRON DEPOT, SIGNIA.
Industry payments across OH — which companies pay providers there.
